The fate of injected Bence Jones protein.

PubWeight™: 1.45‹?› | Rank: Top 5%

🔗 View Article (PMC 2137613)

Published in J Exp Med on April 01, 1963

Authors

F MEYER, F W PUTNAM

Articles by these authors

Biochemical studies of virus reproduction; chemical composition of Escherichia coli bacteriophage T6 and its host. J Biol Chem (1949) 4.98

Molecular kinetic and electrophoretic properties of bacteriophages. Science (1950) 3.91

Biochemical studies of virus reproduction. V. The origin of bacteriophage nitrogen. J Biol Chem (1951) 3.74

Infectious deoxyribonucleic acid from gamma bacteriophage. J Biol Chem (1961) 2.50

Biochemical studies of virus reproduction; purification and properties of Escherichia coli bacteriophage T6. J Biol Chem (1949) 2.15

Biochemical studies of virus reproduction. VIII. Purine metabolism. J Biol Chem (1952) 1.86

The heat precipitation of Bence-Jones proteins. I. Optimum conditions. Arch Biochem Biophys (1959) 1.73

Aberrations of protein metabolism in multiple myeloma; interrelationships of abnormal serum globulins and Bence-Jones proteins. Physiol Rev (1957) 1.70

Proteins in multiple myeloma. III. Origin of Bence-Jones protein. J Biol Chem (1955) 1.69

Proteins in multiple myeloma. I. Physicochemical study of serum proteins. J Biol Chem (1953) 1.64

STRUCTURAL STUDIES OF THE IMMUNOGLOBULINS. I. THE TRYPTIC PEPTIDES OF BENCE-JONES PROTEINS. J Biol Chem (1965) 1.53

Biochemical studies of virus reproduction. IX. Nature of the host cell contributions. J Biol Chem (1952) 1.45

GAMMA GLOBULIN ANTIGENIC TYPES DEFINED BY HEAVY CHAIN DETERMINANTS. Science (1964) 1.39

METABOLISM OF STEAROLIC ACID IN YEAST. J Biol Chem (1963) 1.36

Proteins in multiple myeloma. II. Bence-Jones proteins. J Biol Chem (1953) 1.35

MONOMER--DIMER FORMS OF BENCE JONES PROTEINS. Nature (1963) 1.35

POLYMERISM, POLYMORPHISM, AND IMPURITIES IN BENCE-JONES PROTEINS. Biochim Biophys Acta (1964) 1.34

Proteins in multiple myeloma. VIII. Biosynthesis of abnormal proteins. J Biol Chem (1958) 1.33

Physicochemical properties of bacteriophages. III. Diffusion of bacteriophage T6. J Biol Chem (1951) 1.33

THE CARBOHYDRATE PROSTHETIC GROUP OF HUMAN GAMMA-GLOBULIN. J Biol Chem (1964) 1.31

Proteins in multiple myeloma. V. Synthesis and excretion of Bence-Jones protein. J Biol Chem (1956) 1.28

Antigenic relationships of Bence Jones proteins, myeloma globulins, and normal human gama-globulin. J Exp Med (1963) 1.27

Abnormal human serum globulins. II. Physical constants and amino end groups. J Biol Chem (1958) 1.25

STRUCTURAL STUDY OF HUMAN GAMMA-GLOBULIN THROUGH THE ANALYSIS OF THE TRYPTIC PEPTIDES OF BENCE-JONES PROTEINS. Biochim Biophys Acta (1963) 1.23

IMMUNOGLOBULIN STRUCTURE: AMINO- AND CARBOXYL-TERMINAL PEPTIDES OF TYPE I BENCE JONES PROTEINS. Science (1965) 1.21

The purine metabolism of Escherichia coli. J Biol Chem (1952) 1.19

The cleavage of rabbit gamma-globulin by papain. J Biol Chem (1962) 1.19

Proteins in multiple myeloma. IV. Interaction with metabolic nitrogen. J Biol Chem (1955) 1.18

MYELOMA PROTEINS AND MACROGLOBULINS: HALLMARKS OF DISEASE AND MODELS OF ANTIBODIES. Prog Hematol (1964) 1.17

The cupric ion catalysis of the cleavage of gamma-globulin and other proteins by hydrogen peroxide. J Biol Chem (1961) 1.16

The cleavage of human gamma-globulin by papain. J Biol Chem (1961) 1.15

Site of cleavage of gamma-globulins by papain. Biochim Biophys Acta (1962) 1.14

Plasma-cell myeloma and macroglobulinemia. I. Physicochemical, immunochemical and isotopic turnover studies of the abnormal serum and urinary proteins. N Engl J Med (1959) 1.06

Oxypertine in newly admitted schizophrenics. J New Drugs (1963) 1.05

Proteins in multiple myeloma. VII. The free amino groups of Bence-Jones proteins. J Biol Chem (1957) 0.95

Multiple myeloma: correlation of the clinical, the marrow and electrophoretic findings. Acta Haematol (1956) 0.92

THE SOURCE OF THE APPARENT CARBOHYDRATE CONTENT OF BENCE-JONES PROTEINS. Biochim Biophys Acta (1964) 0.90

The metabolism of DL-glutamic acid-1-C14 in man. J Biol Chem (1958) 0.88

[The state of glycogen in the liver of rats]. C R Hebd Seances Acad Sci (1958) 0.84

[Chromatographic method of determination of serum proteins]. Hoppe Seylers Z Physiol Chem (1950) 0.83

IMIPRAMINE AND THIORIDAZINE IN DEPRESSED AND SCHIZOPHRENIC PATIENTS. ARE THERE SPECIFIC ANTIDEPRESSANT DRUGS? JAMA (1964) 0.83

On the nonidentity of Bence-Jones proteins. Science (1954) 0.80

In vitro incorporation of C14-lysine into Bence-Jones protein. Proc Soc Exp Biol Med (1962) 0.79

Abnormal human serum globulins. Science (1955) 0.79

Proteins in multiple myeloma. VI. Cryoglobulins. Arch Biochem Biophys (1956) 0.78

The interactions of proteins and synthetic detergents. Adv Protein Chem (1948) 0.76

Physiocochemical properties of crystalline Clostridium botulinum type A toxin. J Biol Chem (1948) 0.76

[On the adrenergic action of iproniazid, inhibitor of monoamine oxidase]. C R Hebd Seances Acad Sci (1961) 0.75

Comparative studies of partial hydrolysates of Bence-Jones proteins. J Biol Chem (1960) 0.75

[Preparation and purification of lyo- and desmoglycogen from the rat liver]. C R Hebd Seances Acad Sci (1956) 0.75

Peptide chromatograms of normal human and myeloma gamma-globulins. Biochemistry (1962) 0.75

RESEARCH IN THE DEPARTMENT OF BIOCHEMISTRY OF THE UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE. J Fla Med Assoc (1963) 0.75

Biochemical studies of virus reproduction. X. Precursors of bacteriophage T7. J Biol Chem (1952) 0.75

[Studies on 17 new dialkyl-dihalogenvinyl- and -tetrahalogenethylphosphates. V]. Arzneimittelforschung (1955) 0.75

[ON THE INCIDENCE OF PERIODONTOLYSIS IN YOUNG CHILDREN]. Z Arztl Fortbild (Jena) (1964) 0.75

Physical chemical properties of crystalline botulinus A toxin. Fed Proc (1947) 0.75

[Action of respiratory pancreatic extract on the carbonic anhydrase of rat erythrocytes in vivo]. C R Seances Soc Biol Fil (1961) 0.75

[STOMATOLOGIC SURGERY]. Dtsch Stomatol (1965) 0.75

[The effect of digitalis in heart disease]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1949) 0.75

[Determination of eugenol, isoeugenol, and vanillin]. Arch Pharm Ber Dtsch Pharm Ges (1957) 0.75

The heterogeneity of serum globulins. J Cell Physiol Suppl (1956) 0.75

X-ray diffraction study of sputum in silicosis. AMA Arch Ind Hyg Occup Med (1951) 0.75

Controlled comparison of Haloperidol with thiopropazate in newly admitted schizophrenics. J Nerv Ment Dis (1962) 0.75

[Medical profession and personality]. Arztl Wochensch (1952) 0.75

[Intravenous iron therapy]. Arzneimittelforschung (1951) 0.75

Biologic false positive reactions in serologic tests for syphilis; partial purification of the antibodies of syphilitic human sera by adsorption on freshly precipitated calcium phosphate. Am J Syph Gonorrhea Vener Dis (1947) 0.75

Biochemistry of viruses. Annu Rev Biochem (1956) 0.75

HEMOGLOBIN POLYMORPHISM: ITS RELATION TO SICKLING OF ERYTHROCYTES IN WHITE-TAILED DEER. Science (1964) 0.75

[Detection of pyramidon and other pyrazolone derivatives]. Arzneimittelforschung (1951) 0.75

Molecular weight and homogeneity of crystalline botulinus A toxin. J Biol Chem (1946) 0.75

[Comparative studies on the permeability of skin to some aliphatic vehicles]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1959) 0.75

Purification and properties of E. coli bacteriophage T6. Fed Proc (1948) 0.75

[Bromsulfalein test in psychiatry]. Nervenarzt (1956) 0.75

[Fate of physostigmine in the organism]. Pharmazie (1950) 0.75

[Apropos of the mechanism of action of iproniazid, inhibitor of monoamine oxidase]. Experientia (1961) 0.75

Physicochemical properties of bacteriophages. II. Sedimentation of bacteriophage T6. J Biol Chem (1951) 0.75

Bacteriophages: nature and reproduction. Adv Protein Chem (1953) 0.75

[ON THE CLINICAL PICTURE OF PARADONTOLYSIS IN EARLY CHILDHOOD]. Fortschr Kiefer Gesichtschir (1964) 0.75

Chemical and enzymatic properties of crystalline carboxypeptidase. J Biol Chem (1946) 0.75

[Incorporation of radiocarbon furnished by glucose into the lyoglycogen and desmoglycogen of the rat liver]. C R Hebd Seances Acad Sci (1956) 0.75

[Research on soluble & insoluble glycogen in the rat liver; carbon 14 incorporation with oral glucose as a source]. J Physiol (Paris) (1958) 0.75

[STIMULATION OF INCORPORATION OF AMINO ACIDS INTO PROTEINS OF RABBIT RETICULOCYTES BY 5,6-DIMETHYLBENZIMIDAZOLYLCOBAMIDE-COENZYME]. C R Hebd Seances Acad Sci (1965) 0.75

[Liver damage after prolonged administration of barbiturate derivatives]. Arzneimittelforschung (1955) 0.75

[Prostigmine metabolism in the body]. Arzneimittelforschung (1952) 0.75

[Fate of physostigmine in the organism. 3. Flaveserine A and B]. Arzneimittelforschung (1951) 0.75

Nutritional status of children. XIV. Urinary excretions of thiamine and riboflavin. J Am Diet Assoc (1950) 0.75

[Pharmacology of serium; its effect upon the blood picture of the rabbit]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1950) 0.75

[The time factor in psychiatric treatment method]. Munch Med Wochenschr (1957) 0.75

[Stability of intravenous iron preparations]. Arzneimittelforschung (1957) 0.75

Interaction between proteins and synthetic detergents; molecular-kinetic studies of serum albumin-sodium dodecyl sulfate mixtures. J Biol Chem (1945) 0.75

[Identification of phenothiazine derivatives]. Arzneimittelforschung (1957) 0.75

[Cocarboxylase therapy of diabetic coma]. Paris Med (1951) 0.75

[The significance of the reticuloendothelial system for the pathogenesis and therapy of mental diseases]. Psychiatr Neurol Med Psychol (Leipz) (1956) 0.75

[New research on the incorporation, in the desmoglycogen and the lyoglycogen isolated from the rat liver, of C-14 provided by glucose]. J Physiol (Paris) (1961) 0.75

[Extent of error in blood counting methods]. Klin Wochenschr (1950) 0.75

ULTRACENTRIFUGATION OF PROTEINS AT ELEVATED TEMPERATURES. J Biol Chem (1965) 0.75

PERPHENAZINE COMBINED WITH AMITRYPTILINE IN NEWLY ADMITTED SCHIZOPHRENICS. Am J Psychiatry (1963) 0.75

[Research on 17 new dialkyl-dihalogenvinyl- and tetrahalogenethylphosphates. IV. Circulatory and respiratory effects of the remaining dialkyl-dichlorovinyl- and tetrachloroethylphosphates]. Arzneimittelforschung (1955) 0.75